AAAAAA
Results:
1-23
|
Results: 23
Authors:
Bialer, M
Johannessen, SI
Kupferberg, HJ
Levy, RH
Loiseau, P
Perucca, E
Citation: M. Bialer et al., Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V), EPILEPSY R, 43(1), 2001, pp. 11-58
Authors:
Wasserman, M
Yagen, B
Blotnik, S
Papo, N
Bialer, M
Citation: M. Wasserman et al., Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system-active chiral valproylamide, THER DRUG M, 23(4), 2001, pp. 414-420
Authors:
Isoherranen, N
Yagen, T
Soback, T
Roeder, M
Schurig, V
Bialer, M
Citation: N. Isoherranen et al., Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs, EPILEPSIA, 42(7), 2001, pp. 825-830
Authors:
Isoherranen, N
Woodhead, JH
White, HS
Bialer, M
Citation: N. Isoherranen et al., Anticonvulsant profile of valrocemide (TV1901): A new antiepileptic drug, EPILEPSIA, 42(7), 2001, pp. 831-836
Authors:
Isoherranen, N
Roeder, M
Soback, S
Yagen, B
Schurig, V
Bialer, M
Citation: N. Isoherranen et al., Enantioselective analysis of levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection, J CHROMAT B, 745(2), 2000, pp. 325-332
Authors:
Volosov, A
Bialer, M
Sun, XD
Perucca, E
Sintov, A
Yagen, B
Citation: A. Volosov et al., Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine, J CHROMAT B, 738(2), 2000, pp. 419-425
Authors:
Spiegelstein, O
Kroetz, DL
Levy, RH
Yagen, B
Hurst, SI
Levi, M
Haj-Yehia, A
Bialer, M
Citation: O. Spiegelstein et al., Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid, PHARM RES, 17(2), 2000, pp. 216-221
Authors:
Lindekens, N
Smolders, I
Khan, GM
Bialer, M
Ebinger, G
Michotte, Y
Citation: N. Lindekens et al., In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy, PHARM RES, 17(11), 2000, pp. 1408-1413
Authors:
Britzi, M
Bialer, M
Arcavi, L
Shachbari, A
Kapitulnik, J
Soback, S
Citation: M. Britzi et al., Genetic polymorphism of CYP2D6 and CYP2C19 metabolism determined by phenotyping Israeli ethnic groups, THER DRUG M, 22(5), 2000, pp. 510-516
Authors:
Spiegelstein, O
Yagen, B
Bennett, GD
Finnell, RH
Blotnik, S
Bialer, M
Citation: O. Spiegelstein et al., Stereoselective pharmacokinetic analysis of valnoctamide, a CNS-active chiral amide analogue of valproic acid, in dogs, rats, and mice, THER DRUG M, 22(5), 2000, pp. 574-581
Authors:
Volosov, A
Yagen, B
Bialer, M
Citation: A. Volosov et al., Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemicmixture to dogs, EPILEPSIA, 41(9), 2000, pp. 1107-1111
Authors:
Bialer, M
Citation: M. Bialer, From Vermont to Germany - The life of nurse Carolyne Reed, age 101., AM J NURS, 100(10), 2000, pp. 96T-96T
Authors:
Roeder, M
Spiegelstein, O
Schurig, V
Bialer, M
Yagen, B
Citation: M. Roeder et al., Absolute configuration of the four stereoisomers of valnoctamide (2-ethyl-3-methylvaleramide), a potentially new stereospecific antiepileptic and CNSdrug, TETRAHEDR-A, 10(5), 1999, pp. 841-853
Authors:
Sussan, S
Dagan, A
Blotnik, S
Bialer, M
Citation: S. Sussan et al., The structural requirements for the design of antiepileptic-glycine derivatives, EPILEPSY R, 34(2-3), 1999, pp. 207-220
Authors:
Bialer, M
Johannessen, SI
Kupferberg, HJ
Levy, RH
Loiseau, P
Perucca, E
Citation: M. Bialer et al., Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV), EPILEPSY R, 34(1), 1999, pp. 1-41
Authors:
Sussan, S
Dagan, A
Bialer, M
Citation: S. Sussan et al., Pharmacokinetic analysis and anticonvulsant activity of glycine and glycinamide derivatives, EPILEPSY R, 33(1), 1999, pp. 11-21
Authors:
Spiegelstein, O
Bialer, M
Radatz, M
Nau, H
Yagen, B
Citation: O. Spiegelstein et al., Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acid, CHIRALITY, 11(8), 1999, pp. 645-650
Authors:
Spiegelstein, O
Yagen, B
Levy, RH
Finnell, RH
Bennett, GD
Roeder, M
Schurig, V
Bialer, M
Citation: O. Spiegelstein et al., Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid, PHARM RES, 16(10), 1999, pp. 1582-1588
Authors:
Bialer, M
Citation: M. Bialer, Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs, J CONTR REL, 62(1-2), 1999, pp. 187-192
Authors:
Volosov, A
Sintov, A
Bialer, M
Citation: A. Volosov et al., Stereoselective pharmacokinetic analysis of the antiepileptic 10-hydroxycarbazepine in dogs, THER DRUG M, 21(2), 1999, pp. 219-223
Authors:
Volosov, A
Bialer, M
Citation: A. Volosov et M. Bialer, Use of mean residence time to determine the magnitude of difference between rate constants and to calculate t(max) in the Bateman equation, BIOPHARM DR, 20(1), 1999, pp. 3-9
Authors:
Spiegelstein, O
Yagen, B
Bialer, M
Citation: O. Spiegelstein et al., Structure-pharmacokinetic-pharmacodynamic relationships of N-alkyl derivatives of the new antiepileptic drug valproyl glycinamide, EPILEPSIA, 40(5), 1999, pp. 545-552
Authors:
Volosov, A
Sun, XD
Perucca, E
Yagen, B
Sintov, A
Perucca, E
Yagen, B
Sintov, A
Bialer, M
Citation: A. Volosov et al., Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects, CLIN PHARM, 66(6), 1999, pp. 547-553
Risultati:
1-23
|